Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.6K
Genetic Lingo01:11

Genetic Lingo

113.4K
Overview
113.4K
Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

9.3K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
9.3K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

915
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
915

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same author

Extended follow-up of ultrastructural remodeling and functional recovery after lamellar macular hole surgery using autologous platelet-rich plasma.

Scientific reports·2026
Same author

Transitional Life Events in Friedreich Ataxia: Differential Age at Onset Perspectives.

Cerebellum (London, England)·2026
Same author

Cerebellar cognitive-affective syndrome in Friedreich Ataxia.

Journal of neurology·2026
Same author

Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis.

Nature reviews. Nephrology·2026
Same author

Deferoxamine Modulates Corneal Endothelial Cell Biological Properties Associated with Increased VEGF Expression.

Medicina (Kaunas, Lithuania)·2026
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

19.9K

[Leber's Hereditary Optic Neuropathy].

Claudia Priglinger1, Thomas Klopstock2,3,4, Günter Rudolph1

  • 1Augenklinik, Klinikum der Ludwig-Maximilians-Universität München.

Klinische Monatsblatter Fur Augenheilkunde
|October 23, 2019
PubMed
Summary
This summary is machine-generated.

Leber's hereditary optic neuropathy (LHON) is a mitochondrial DNA disease causing vision loss. Early Idebenone treatment offers hope, but research continues into its complex causes and potential therapies.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.9K

Related Experiment Videos

Last Updated: Jan 5, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

19.9K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.9K

Area of Science:

  • Genetics and Ophthalmology
  • Mitochondrial Biology
  • Neuroscience

Background:

  • Leber's hereditary optic neuropathy (LHON) is a genetic disorder affecting the optic nerve.
  • It is caused by mutations in mitochondrial DNA, impacting Complex I of the respiratory chain.
  • This leads to retinal ganglion cell dysfunction and optic atrophy, typically in young adults.

Purpose of the Study:

  • To provide an overview of LHON's clinical course, diagnostics, and current therapies.
  • To discuss the special features, incomplete penetrance, and underlying pathogenesis of LHON.
  • To highlight ongoing research into alternative therapeutic approaches and clarify remaining questions about the disease.

Main Methods:

  • Review of clinical presentation and natural history of LHON.
  • Analysis of diagnostic criteria and current treatment recommendations, including Idebenone.
  • Exploration of current research in gene therapy, neuroprotection, and stem cell-based treatments.

Main Results:

  • LHON typically presents as subacute unilateral vision loss, progressing to the fellow eye.
  • The majority of patients have persistent visual acuity below 0.1, with rare spontaneous recovery.
  • Idebenone, approved in 2015, requires early initiation and appropriate duration for therapeutic success, though complete recovery is uncommon.

Conclusions:

  • Early diagnosis and treatment with Idebenone are crucial for managing LHON, alongside essential visual aids and rehabilitation.
  • Further research is needed to fully understand LHON's pathogenesis, including gender prevalence and contributing factors.
  • Emerging therapies like gene therapy offer future hope for patients with this debilitating optic neuropathy.